Aims: Blood contact with foreign surfaces in the apheresis systems may activate many cell types that return back to the donor. However, the safety issue regarding post-procedure platelet activation is not well assessed. We aimed to evaluate the alterations in hematological parameters and to explore the formation of platelets leukocytes aggregates (PLAs) and/or complexes in healthy donors who underwent first-time plateletpheresis procedure. Methods: Blood from 100 healthy donors were assessed by BD FACS Calibur flow cytometer for: a) detection of PLAs using (CD41, CD42b, CD61) antibodies against platelets surface molecules to detect its expression on neutrophils, monocytes, lymphocytes, and b) evaluation of red cell mechanical fragility (RBC-MF). Results: After donation a significant decrement of donor blood cell counts; the percent (%) reduction in hemoglobin (Hb) 7.9(5.1-9.2) (p = 0.017), hematocrit (Hct) 6(2.72-7.81) (p = 0.043) %, residual red cells (p = 0.016), platelet count (PLT) 22.7(9.5-32) (p = 0.031) together with a significant increase in the MPV (p = 0.001), the absolute neutrophil (p = 0.026) and lymphocyte
Aim of the work: to evaluate the effect of intravenous dexmedetomidine infusion on patients undergoing open heart surgery regarding stress response markers as plasma interleukin-6 and plasma cortisol. Patents and Methods: Fifty consecutive patients aged 18-70years, scheduled for elective open heart surgery using CPB technique were enrolled in this study at the Cardiothoracic Surgery Unit, Luxor international hospital, from July 2018 to May 2019. Patients randomly assigned using closed envelope technique into two equal groups according to the drug infused intraoperatively: 1 st group (25 patients):-Dexmedetomidine group (Group D); received loading dose of intravenous dexmedetomidine infusion of 1 μg/kg IV dissolved in 20ml normal saline over 10 minutes followed by maintenance dose of 0.5 μg/kg/hr. till the end of surgery where 0.5 μg /kg/h was calculated for each patient and dissolved in 12.5 ml normal saline 2 nd group (25 patients):-placebo group (Group P); receive 20ml intravenous infusion of normal saline 0.9 % over 10 minutes followed by continuous infusion of 12.5 ml of normal saline till the end of surgery. Results: Our study revealed that HR and MAP wasn't significantly different between the two groups at the baseline, but significantly lowered in Dex. group after induction, during CPB, post CPB, and postoperative.Dexometomedine suppress the intraoperative and postoperative rise of IL-6 which was significantly higher in placebo group relative to Dex. group. Also dexometomedine has effect on stress hormone as serum cortisol and serum glucose decease in Dex. group relative to placebo group. None of studied cases revealed bradycardia or hypotention and there are no significant difference between groups regarding side effect drowsiness, nausea and vomiting Conclusion: This study demonstrated that the continuous administration of dexmedetomidine during open heart surgery with CPB suppressed intraoperative and post-operative cytokine secretion, and improved post-operative inflammatory response indices in the present study. Also it stabilize blood pressure and heart rate and blunt cardiovascular response to CPB. These results could be attributed to the anti-inflammatory effects of dexmedetomidine.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.